Sandy Draper
Stock Analyst at Guggenheim
(2.94)
# 1,537
Out of 4,944 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $460.95 | -6.28% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $188.15 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $153.16 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $8.88 | +282.88% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $3.47 | +188.60% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $62.99 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.52 | -43.18% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $175.62 | +49.76% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $1.07 | +2,716.90% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $87.70 | +7.18% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.18 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $20.70 | +146.38% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $156.72 | -17.69% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $29.86 | +84.19% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $44.67 | +276.09% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $45.98 | -73.90% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $24.45 | +55.42% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $4.61 | +984.60% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $6.15 | +956.91% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.96 | +1,116.22% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $274.80 | -39.23% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.66 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $13.75 | +358.18% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $460.95
Upside: -6.28%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $188.15
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $153.16
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $8.88
Upside: +282.88%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $3.47
Upside: +188.60%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $62.99
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.52
Upside: -43.18%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $175.62
Upside: +49.76%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.07
Upside: +2,716.90%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $87.70
Upside: +7.18%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.18
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $20.70
Upside: +146.38%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $156.72
Upside: -17.69%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $29.86
Upside: +84.19%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $44.67
Upside: +276.09%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $45.98
Upside: -73.90%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $24.45
Upside: +55.42%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $4.61
Upside: +984.60%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $6.15
Upside: +956.91%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.96
Upside: +1,116.22%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $274.80
Upside: -39.23%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.66
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $13.75
Upside: +358.18%